Greenwings Biomedical, Inc.
Richard Koffler is a seasoned executive with extensive experience in the biomedical and technology industries. Currently serving as CEO of Greenwings Biomedical, Richard focuses on translating university research into FDA-cleared medical solutions, emphasizing innovative algorithms and digital health products. Richard has also contributed as a board member at Alelo, where the emphasis is on AI-driven learning simulations. Previous roles include CEO of SynTouch, Inc., where technology was developed to quantify human touch, and CEO of HEAL Clinics, addressing public health crises through ketogenic lifestyle programs. Richard founded Viderics Inc. to advance echocardiography systems and has been an advisor to multiple organizations, including the California Emerging Technology Fund. An alumnus of the Massachusetts Institute of Technology and the University of California, Berkeley, Richard holds degrees in Computer Science and has been active in angel investing through Tech Coast Angels and LatinoCities, Inc.
This person is not in any teams
Greenwings Biomedical, Inc.
Our mission is to translate intellectual property invented at university research labs into FDA-cleared, commercial-ready medical solutions that we either launch commercially or sell to established companies. Our goal is to significantly improve the cost and quality of healthcare by advancing clinician productivity, clinical decision support, personalized medicine, non-invasive therapy, coordination of care, and patient management and engagement. Our focus is on clinical decision support systems, biomedical devices and digital-health products enabled at their core by highly innovative algorithms and software-based intelligence.